Anondita Medicare
- Market cap
- ₹ 1,885 Cr.
- P/E
- 56.5x
- P/B
- 13.79x
- 52-week range
- 512.14 – 1,309.58
- ROE
- 40%
- ROCE
- 44%
- Dividend yield
- 0%
- Debt / equity
- 0.26
- Sector
- Personal Products
- Industry
- Personal Care
- Listed on
- NSE SME
About
Anondita Medicare Limited is an India-based manufacturer of male condoms with a variety of flavors, with its flagship product marketed and sold under the brand COBRA. It offers condoms in different flavors, such as strawberry, mint, chocolate, butterscotch, coffee and bubblegum. It uses export quality packing material. Its sales channel partners include Anondita Healthcare and Rubber Products India Limited, super distributor/stockiest, other/third party distributors, and government procurement agencies. The Company also sells its products directly to several Government Procurement Agencies and AIDS Control Societies (with the government's own labelling and packaging). The Company has an installed production capacity of approximately 562 million condoms per annum. Its subsidiaries include Anondita Healthcare Products Private Limited, Anondita Latex Products (India) Private Limited, Anondita Healthcare Private Limited, and Anondita Healthcare and Rubber Products India Limited.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Personal Care: 22 companies →Anondita Medicare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)56.5 against a typical 33.9: pricier than most peers (1st = cheapest).16th of 22
- Share price, 3 months−6.6% against a typical −6.6%.9th of 19
- Size₹ 1,885.4 Cr. market value against a typical ₹ 188.1 Cr. (1st = largest).7th of 19
Research by Minerva Capital Research Solutions
Our research team's work on Anondita MedicareAlso covered in
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 7 Aug 2026 | Board Meeting Intimation | ANONDITA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2026 to consider Fund raising. |
| 1 Aug 2026 | Fund Raising | To consider Fund Raising by way of issuance of equity shares through a rights issue |
| 22 May 2026 | Financial Results | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company along with Audit Report, for the half year and financial year ended March 31, 2026 |
| 30 Apr 2026 | Fund Raising | To consider Fund Raising |
| 13 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 31 | 46 | 54 | 83 |
| Expenses | 22 | 30 | 35 | 52 |
| Operating Profit | 10 | 16 | 19 | 31 |
| OPM % | 31% | 35% | 35% | 38% |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 1 |
| Profit before tax | 8 | 14 | 17 | 30 |
| Tax % | 25% | 26% | 25% | 28% |
| Net Profit | 6 | 10 | 13 | 21 |
| EPS in Rs | 4.07 | 7.28 | 6.77 | 9.97 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 78%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 111%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Anondita Medicare | ₹ 1,000.00 | ₹ 1,885 Cr. | 56.5x | 13.8x | 40% | — |
| Supreme Industries | ₹ 3,450.00 | ₹ 43,824 Cr. | 45.6x | 7.1x | 16.1% | 8.5% |
| Astral | ₹ 1,353.00 | ₹ 36,348 Cr. | 66.9x | 9.1x | 14% | 8.1% |
| PG Electroplast | ₹ 472.00 | ₹ 13,535 Cr. | 90.6x | 5.8x | 6.7% | 3.7% |
| Garware Hi-Tech Films | ₹ 7,037.90 | ₹ 16,351 Cr. | 149.7x | 6.1x | 13.5% | 16% |
| Tega Industries | ₹ 1,721.60 | ₹ 12,919 Cr. | 79x | 3.6x | 5.9% | 8.4% |
Management
- Sunita Naithani
- Chief Financial Officer
- Nutan Agrawal
- Company Secretary, Compliance Officer
- Anupam Ghosh
- Managing Director, Executive Director
- Reshant Ghosh
- Whole Time Director
- Sonia Ghosh
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.